TY - JOUR
T1 - Apoptosis and myocardial infarction
T2 - role of ncRNAs and exosomal ncRNAs
AU - Farokhian, Alireza
AU - Rajabi, Ali
AU - Sheida, Amirhossein
AU - Abdoli, Amirhossein
AU - Rafiei, Moein
AU - Jazi, Zahra Hadian
AU - Asouri, Sahar Ahmadi
AU - Morshedi, Mohammad Amin
AU - Hamblin, Michael R.
AU - Adib-Hajbagheri, Parisa
AU - Mirzaei, Hamed
N1 - Publisher Copyright:
© 2023 Future Medicine Ltd.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - ncRNAs, particularly miRNAs, lncRNAs and circRNAs, are a group of RNAs which, although they do not encode proteins (however, recent evidence shows that certain circRNAs are translatable), play a major role in regulating gene expression and, therefore, affect multiple cellular processes, in particular apoptosis. Apoptosis is proven to mediate myocardial infarction physiopathology in addition to ischemic necrosis and, therefore, has recently gained great interest as a target to improve MI outcomes. The current work reviews studies that have assessed ncRNAs with the ability to promote or suppress apoptosis in the process of MI and, therefore, may introduce new therapeutic targets for MI treatment.
AB - ncRNAs, particularly miRNAs, lncRNAs and circRNAs, are a group of RNAs which, although they do not encode proteins (however, recent evidence shows that certain circRNAs are translatable), play a major role in regulating gene expression and, therefore, affect multiple cellular processes, in particular apoptosis. Apoptosis is proven to mediate myocardial infarction physiopathology in addition to ischemic necrosis and, therefore, has recently gained great interest as a target to improve MI outcomes. The current work reviews studies that have assessed ncRNAs with the ability to promote or suppress apoptosis in the process of MI and, therefore, may introduce new therapeutic targets for MI treatment.
KW - apoptosis
KW - circRNA
KW - exosome
KW - lncRNA
KW - miRNAs
KW - myocardial infarction
KW - ncRNAs
UR - http://www.scopus.com/inward/record.url?scp=85160876020&partnerID=8YFLogxK
U2 - 10.2217/epi-2022-0451
DO - 10.2217/epi-2022-0451
M3 - Review article
C2 - 37194609
AN - SCOPUS:85160876020
SN - 1750-1911
VL - 15
SP - 307
EP - 334
JO - Epigenomics
JF - Epigenomics
IS - 5
ER -